Sarcoidosis in chronic granulomatous disease

Pediatrics

Volumn 117, Issue 3, 2006, Pages

  De Ravin, Suk See ^a   Naumann, Nora ^a   Robinson, Michael R ^b   Barron, Karyl S ^a   Kleiner, David E ^c   Ulrick, Jean ^a   Friend, Julia ^a   Anderson, Victoria L ^a   Darnell, Dirk ^a   Kang, Elizabeth M ^a   Malech, Harry L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiotensin converting enzyme; Chronic granulomatous disease; Neurosarcoidosis; Sarcoidosis

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFTAZIDIME; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON; ITRACONAZOLE; LEVOFLOXACIN; METHOTREXATE; MOXIFLOXACIN; PREDNISONE; RIFAMPICIN; STEROID; VANCOMYCIN;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG PULSE THERAPY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GRANULOMATOSIS; HUMAN; INFANT; LABORATORY TEST; LOADING DRUG DOSE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOGRAPHY; SARCOIDOSIS; SCHOOL CHILD; SEROLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHRONIC GRANULOMATOUS DISEASE; MALE;

ADOLESCENT; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MALE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 33645022945     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1349     Document Type: Article

References (29)

1. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169
2. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol. 2003;15:578-584
3. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397-407
4. Popper HH. Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:32-46
5. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224-1234
6. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy. 2005;60:565-582
7. Schnabel A, Barth J, Schubert F, Gross WL. Pulmonary sarcoidosis coexisting with systemic lupus erythematosus. Scand J Rheumatol. 1996;25:109-111
8. Fivenson DP, Crump G, Scheele P, Breneman DL. Systemic lupus erythematosus developing in a patient with longstanding pulmonary sarcoidosis. J Rheumatol. 1989;16:1116-1119
9. Begum S, Li C, Wedderburn LR, Blackwell V, Isenberg DA. Concurrence of sarcoidosis and systemic lupus erythematosus in three patients. Clin Exp Rheumatol. 2002;20:549-552
10. Shorr AF, Torrington KG, Parker JM. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med. 1997;91:399-401
11. Farrell AM, Henry K, Woodrow D, et al. Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma. Br J Dermatol. 1999;140:145-149
12. Constantino T, Digre K, Zimmerman P. Neuro-ophthalmic complications of sarcoidosis. Semin Neurol. 2000;20:123-137
13. Uyama M. Uveitis in sarcoidosis. Int Ophthalmol Clin. 2002;42:143-150
14. Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780-783
15. Gelwan MJ, Kellen RI, Burde RM, Kupersmith MJ. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry. 1988;51:1473-1480
16. Hadfield MG, Ghatak NR, Laine FJ, Myer EC, Massie FS, Kramer WM. Brain lesions in chronic granulomatous disease. Acta Neuropathol (Berl). 1991;81:467-470
17. Agus S, Spektor S, Israel Z. CNS granulomatosis in a child with chronic granulomatous disease. Br J Neurosurg. 2000;14:59-61
18. Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23:360-365
19. Whitsett CF, Merritt JC, Mower P, Daffin L. HLA-A, B and DR antigens in North Carolina blacks with sarcoidosis. Tissue Antigens. 1983;21:348-350
20. Lynch JP 3rd. Neurosarcoidosis: how good are the diagnostic tests? J Neuroophthalmol. 2003;23:187-189
21. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173
22. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest. 1993;103:832-838
23. Tavares JL, Wangoo A, Dilworth P, Marshall B, Kotecha S, Shaw RJ. Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages. Respir Med. 1997;91:31-39
24. Baughman RP. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med. 2002;8:464-469
25. Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs. 2003;17:425-431
26. Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146-2155
27. Warris A, Netea MG, Wang JE, et al. Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis. 2003;35:482-487
28. Hatanaka E, Carvalho BT, Condino-Neto A, Campa A. Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol Lett. 2004;94:43-46
29. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol. 2004;5:818-827